Guardion Health Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2024 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q3 2024 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q4 2024 | 1 | -$0.28 | -$0.28 | -$0.28 |
Guardion Health Sciences, Inc. Earnings Date And Information
Guardion Health Sciences, Inc. last posted its earnings results on Thursday, March 28th, 2024. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $-0.73 by $1.06. The company had revenue of 72,918 for the quarter and had revenue of 12.25 M for the year. Guardion Health Sciences, Inc. has generated $0 earnings per share over the last year ($0.12 diluted earnings per share) and currently has a price-to-earnings ratio of -0.7. Guardion Health Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Guardion Health Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$1.50 | $3.21 M | $72,918 | ||
| 05/13/2024 | Q1 2024 | -$3.71 | $3.00 M | |||
| 03/28/2024 | Q4 2023 | $0.33 | $2.94 M | |||
| 11/13/2023 | Q3 2023 | -$0.87 | $0.29 | 1.16 | $3.08 M | $3.34 M |
| 08/14/2023 | Q2 2023 | -$0.93 | -$0.93 | 0 | $2.78 M | $2.79 M |
| 05/15/2023 | Q1 2023 | -$1.13 | $2.00 | 3.13 | $3.19 M | |
| 05/01/2023 | Q4 2022 | -$19.13 | $2.73 M | |||
| 11/14/2022 | Q3 2022 | -$1.00 | -$1.38 | -0.38 | $3.55 M | $2.66 M |
| 08/11/2022 | Q2 2022 | -$1.13 | -$1.38 | -0.25 | $2.60 M | $3.28 M |
| 05/12/2022 | Q1 2022 | -$3.11 | -$3.37 | -0.26 | $2.38 M | |
| 03/31/2022 | Q4 2021 | -$0.01 | $2.63 M | |||
| 11/10/2021 | Q3 2021 | -$6.17 | $3.15 M | |||
| 08/16/2021 | Q2 2021 | -$9.29 | $1.22 M | |||
| 05/17/2021 | Q1 2021 | -$6.25 | $233,297 | |||
| 03/26/2021 | Q4 2020 | -$0.00 | $200,024 | |||
| 11/12/2020 | Q3 2020 | -$7.28 | $253,188 | |||
| 08/12/2020 | Q2 2020 | -$2.45 | $1.19 M | |||
| 05/14/2020 | Q1 2020 | -$8.95 | $245,723 | |||
| 03/30/2020 | Q4 2019 | -$0.01 | $238,268 | |||
| 11/13/2019 | Q3 2019 | -$19.86 | $161,162 |
Guardion Health Sciences, Inc. Earnings: Frequently Asked Questions
-
When is Guardion Health Sciences, Inc.'s earnings date?
Guardion Health Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
Did Guardion Health Sciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Guardion Health Sciences, Inc. (:GHSI) reported $0.33 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.73 by $1.06.
-
How can I listen to Guardion Health Sciences, Inc.'s earnings conference call?
The conference call for Guardion Health Sciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Guardion Health Sciences, Inc.'s conference call transcript?
The conference call transcript for Guardion Health Sciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Guardion Health Sciences, Inc. generate each year?
Guardion Health Sciences, Inc. (:GHSI) has a recorded annual revenue of $12.25 M.
-
How much profit does Guardion Health Sciences, Inc. generate each year?
Guardion Health Sciences, Inc. (:GHSI) has a recorded net income of $12.25 M. Guardion Health Sciences, Inc. has generated $0.12 earnings per share over the last four quarters.
-
What is Guardion Health Sciences, Inc.'s price-to-earnings ratio?
Guardion Health Sciences, Inc. (:GHSI) has a price-to-earnings ratio of -0.7 and price/earnings-to-growth ratio is 0.05.
